isoxazoles has been researched along with Ventricular Dysfunction, Left in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Gao, E; Guo, Y; Li, C; Li, Y; Liu, Y; Tao, L; Wang, H; Wang, S; Wang, W; Xia, Y; Xiong, Z; Xu, X; Yan, W; Zhang, F; Zhang, J; Zhang, L; Zhang, X; Zhao, H; Zhao, S | 1 |
| Deardorff, RL; Ikonomidis, JS; Mulcahy, J; Spinale, FG; Szeto, WY; Toole, JM; Zellner, JL | 1 |
1 trial(s) available for isoxazoles and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Selective endothelin-1 receptor type A inhibition in subjects undergoing cardiac surgery with preexisting left ventricular dysfunction: Influence on early postoperative hemodynamics.
Topics: Aged; Cardiopulmonary Bypass; Endothelin A Receptor Antagonists; Female; Hemodynamics; Humans; Isoxazoles; Male; Middle Aged; Postoperative Complications; Postoperative Period; Prospective Studies; Risk Factors; Single-Blind Method; Thiophenes; Time Factors; Ventricular Dysfunction, Left | 2010 |
1 other study(ies) available for isoxazoles and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Topics: 3T3-L1 Cells; Adiponectin; Animals; Apoptosis; Disease Models, Animal; Heart Ventricles; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Myocardial Infarction; Myocytes, Cardiac; Organelle Biogenesis; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2018 |